This trial is active, not recruiting.

Condition hip arthritis
Sponsor Aesculap AG
Start date September 2014
End date November 2015
Trial size 100 participants
Trial identifier NCT02188095, AAG-O-H-1401


Clinical and radiological 3 year results of Excia T® Hip Stem

United States No locations recruiting
Other countries No locations recruiting

Study Design

Observational model cohort
Time perspective prospective

Primary Outcomes

Survival Rate of the Implant
time frame: 10 years

Secondary Outcomes

Hip disability and Osteoarthritis Outcome Score (HOOS)
time frame: 10 years
Harris Hip Score (HHS)
time frame: 10 years
time frame: 10 years
Shaftposition ap and lateral
time frame: 10 years
Stress Shielding
time frame: 10 years
time frame: 10 years

Eligibility Criteria

All participants at least 18 years old.

Inclusion Criteria: - Patient gave written informed consent - age ≥ 18 years Exclusion Criteria: - pregnancy

Additional Information

Official title Post Market Clinical Follow-Up Study of Excia T® Hip Prosthesis
Principal investigator Peter Aldinger, Prof. Dr.
Trial information was received from ClinicalTrials.gov and was last updated in January 2017.
Information provided to ClinicalTrials.gov by Aesculap AG.